Sunesis Pharmaceuticals (SNSS) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
General and administrative: 4M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
General and administrative: 4M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q3 EPS of ($0.09), $0.06 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $700 thousand versus the consensus estimate of $1.09 million.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- OMNIQ Corp. posts Q2 2026 revenue of $7.4M, widens net loss
- Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
